• Tuesday, Jun 28, 2022
  • Last Update : 04:24 pm

Study: Antibodies detected in 98% of vaccine recipients

  • Published at 10:59 pm May 1st, 2021
vaccine bangladesh-mehedi
File Photo: India's Serum Institute of India (SII) is set to export 1 million Covishield doses to Bangladesh in October Mehedi Hasan/Dhaka Tribune

Antibody levels above 6 contribute to reducing the severity of Covid-19 significantly, say experts

A self-funded research conducted by a couple of tertiary level hospital physicians has found that the Oxford-AstraZeneca vaccine is developing antibodies in people who have received the jab.

The level of antibodies developed post-vaccination is not the same for all. But the researchers have initially found that antibodies had developed in over 98% of the recipients after they had taken the first dose of the two-dose vaccine.

They also observed that the level of antibodies ranged from 2 to 12, and younger people (20 to 50 years old) were developing higher levels of immunity compared to the elderly (60 and above).

A health worker takes the temperature of a possible Covid-19 suspect ahead of testing
| Mahmud Hossain Opu

Dr Biddut Barun, deputy director (planning and development) of Chittagong Medical University (CMU), in early April told Dhaka Tribune that the antibody level in his blood was above 9 after taking the vaccine.

“It is believed that antibody levels above 6 contribute to reducing the severity [of Covid-19] significantly,” he said, adding that the country needed to conduct more studies on vaccines.


The second phase of the aforesaid research has almost reached its completion.

To conduct the study, the physicians first tested antibody levels before the participants had been vaccinated. The second blood sample was collected 28 days after the administration of the first dose of the vaccine.

Testing of the antibody levels was ongoing, said Ashraful Haque, assistant professor at Sheikh Hasina National Institute of Burn and Plastic Surgery.

Research findings showed that the level of antibody in people between the ages 20 and 50 was 10-12.

Also Read - Serum Institute plans to start vaccine production outside India

The antibody level was around 6 or more among people above 60, and had never crossed 10, Ashraful Haque, one of the researchers, said.

In line with current belief, another study, conducted by Chittagong Veterinary and Animal Sciences University (CVASU), has found after testing 200 Covid-19 patients that those who have received their first vaccine dose are less likely to experience severe symptoms.

“Vaccine confers passive immunity through the creation of antibodies to fight the virus,” Assistant Professor Ashraful said, adding: “The main objective of vaccination is to reduce severe cases and hospitalizations, [consequently] bringing down the mortality rate.”

Also Read -Study: Children have stronger antibody response to Covid-19

“[However,] vaccination does not put an end to the spread of coronavirus … a full clinical trial of the vaccine has yet to be completed. It takes several years to make such a vaccine, and we got it in a year,” he stated.

The researchers of the antibody study have noted that seven out of 500 vaccinated participants tested Covid-19 positive after receiving the first shot.

The Indian Express on Friday reported that some 0.02% of people in India had contracted the virus after taking the first dose of Covishield, the Oxford-AstraZeneca jab manufactured by Serum Institute of India, while around 0.03% had tested positive for the disease after taking the second dose.

Hope in the storm

“The level of antibody [in a vaccine recipient’s body] will increase over time. A booster shot will be needed in the future,” Ashraful Haque said.

The health authorities in the UAE and Israel have already started administering a third vaccine dose as a booster shot.

Holding out hope, the assistant professor said the research was providing evidence that vaccination could prevent severe cases and save lives in the process.

“As the vaccine is creating antibodies in the elderly at around level 6, more of them could remain out of harm’s way after being vaccinated,” he remarked. 

Meanwhile, Dr Biddut Barun of CMU said if 70-80% of the total population was inoculated, the country might be in a safer state.

Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail